U.S. Markets close in 3 hrs 19 mins

Free Research Report as H.B. Fuller's Revenues Surged 41% and Adjusted EPS Advanced 44%

Stock Monitor: OMNOVA Solutions Post Earnings Reporting

LONDON, UK / ACCESSWIRE / July 16, 2018 / If you want access to our free earnings report on H.B. Fuller Co. (NYSE: FUL), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=FUL. The Company reported its second quarter fiscal 2018 operating and financial results on June 27, 2018. The adhesives Company surpassed earnings expectations. Additionally, the Company updated its guidance for FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:


Active-Investors.com is currently working on the research report for OMNOVA Solutions Inc. (OMN), which also belongs to the Basic Materials sector as the Company H.B. Fuller. Do not miss out and become a member today for free to access this upcoming report at:


Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, H.B. Fuller most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:


Earnings Highlights and Summary

For the second quarter ended June 02, 2018, H.B. Fuller's net revenues soared 40.5% to $789.4 million, and was driven by the addition of the Royal Adhesives & Sealants ("Royal") business which was acquired in September 2017 for $1.575 billion. The Company's pro-forma organic revenue growth, including Royal, increased approximately 3.5% on a y-o-y basis, primarily driven by pricing, as well as volume/mix. H.B. Fuller's revenue numbers lagged analysts' estimates of $808.1 million.

During Q2 FY18, H.B. Fuller's gross profit margin was 28.2%. The Company's adjusted gross profit margin was 28.3% in the reported quarter, up 30 basis points (bps) versus the prior year's same quarter on a pro-forma basis, including Royal, and reflecting a positive pricing contribution and realized raw material synergies.

For Q2 FY18, H.B. Fuller's selling, general, and administrative expenses (SG&A) were $145.2 million. The Company's adjusted SG&A grew by about 6% on a pro-forma basis versus Q2 FY17, due to acquisitions and foreign exchange but declined as a percentage of revenues on a y-o-y basis, by approximately 30 bps due to sales leverage and overall cost controls.

H.B. Fuller's adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) totaled $123 million in Q2 FY18, up 72% on a y-o-y basis, or 12% higher on a pro-forma basis, including Royal.

H.B. Fuller's net income was $44.5 million, or $0.86 per diluted share, in Q2 FY18 versus $25.9 million, or $0.50 per diluted share, in Q2 FY17. The Company's adjusted diluted earnings per share (EPS) was $0.89 in the reported quarter, up 44% compared to $0.62 in the prior year's corresponding quarter. H.B. Fuller's EPS surpassed Wall Street's estimates of $0.86.

Royal Integration

H.B. Fuller stated that the Royal integration is progressing well and generated an incremental $4 million in cost synergies in Q2 FY18, totaling $6 million year-to-date, in-line with expectations. The Company's target remains to realize a total of $15 million of cost synergies in FY18 and $35 million of savings by FY20.

Balance Sheet and Cash Flow

As of June 02, 2018, H.B. Fuller had cash on hand of $129 million and total debt equal to $2.41 billion, of which approximately 70% had a fixed interest rate. This compares to cash and debt levels equal to $132 million and $2.44 billion, respectively, in Q1 FY18.

H.B. Fuller's cash flow from operations was $54 million in Q2 FY18, reflecting the improving profitability of the businesses. Out of the total cash generated from operations, $36 million was used to repay debt. The Company stated that it remains on track to meet its $170 million debt reduction goal for FY18.


H.B. Fuller narrowed its adjusted EPS guidance range to $3.15 to $3.40 for FY18 versus the previous range of $3.10 to $3.40. The Company also updated its adjusted EBITDA guidance to approximately $470 million, so as to reflect the impact of the modified calculation of EBITDA.

For the remainder of FY18, H.B. Fuller is projecting revenue growth to be between 5% and 6% on a pro-forma basis compared to FY17. H.B. Fuller expects to invest a total of approximately $80 million in capital items in FY18.

Stock Performance Snapshot

July 13, 2018 - At Friday's closing bell, H.B. Fuller's stock slightly dropped 0.59%, ending the trading session at $55.81.

Volume traded for the day: 209.66 thousand shares.

Stock performance in the last month – up 0.52%; previous three-month period – up 12.36%; past twelve-month period – up 9.11%; and year-to-date – up 3.60%

After last Friday's close, H.B. Fuller's market cap was at $2.82 billion.

Price to Earnings (P/E) ratio was at 39.11.

The stock has a dividend yield of 1.11%.

The stock is part of the Basic Materials sector, categorized under the Specialty Chemicals industry. This sector was up 0.3% at the end of the session.

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit



For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities